ArticleAnalytical cellular pathology (Amsterdam)2021

Anlotinib Suppresses Oral Squamous Cell Carcinoma Growth and Metastasis by Targeting the RAS Protein to Inhibit the PI3K/Akt Signalling Pathway.

Yunfei Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.